Amgen Undergrad Intern - Process Development Drug Product in Puerto Rico, Puerto Rico

Amgen is looking for self-motivated individuals, with strong analytical skills, decision-making, and leadership attributes, willing to join a Biotechnology World Class Company under our University Relations Program.

The Undergrad-Intern will apply the skills learned at the university in the pharmaceutical industry and learn new ones from hands on experience of work assignment. Key skills include but are not limited to: communication, planning, organization, problem solving, team-working, data monitoring etc.

This position is based in Juncos, Puerto Rico for Drug Product - Process Development department. Amgen Manufacturing Limited is chosen one of the top 3 Best Employers in Puerto Rico. The selected candidate will start in May 2019.

Specific responsibilities include but are not limited to:

  • Evaluation of the historical and current data

  • Define/develop standard works (protocols/procedures) for specific tasks

  • Prepare project justification

  • Meeting coordination with interdepartmental groups for agreement on path forward

  • Identify efficiency opportunities

  • Communicate with people in diverse language ability, educational levels and experiences

EDUCATION/LICENSES

At least 3.00 GPA (General)

Be in the process of earning a bachelor’s degree in Biomedical Engineering

Be enrolled in university

All individuals applying for an internship or a co-op assignment at Amgen need to meet the following criteria:

Have not graduated yet

Be pursuing an applicable degree or course of study

PREFERRED QUALIFICATIONS

Be enroll in school under a Coop program

Strong technical writing skills

Good interpersonal skills

Able to work with minimum supervision

Well Organized

Meet milestones and deliver high quality results

Enthusiastic about learning new concepts and work processes

Proficient in the following software: MS Excel, MS Word, MS Power Point

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.